Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "sales"

1324 News Found

Gland Pharma receives tentative nod for Sugammadex injection
Drug Approval | October 09, 2021

Gland Pharma receives tentative nod for Sugammadex injection

The injection is used to reverse the effects of the muscle relaxants given to patients during surgery


Lincoln Pharma gets Australian TGA approval
News | October 08, 2021

Lincoln Pharma gets Australian TGA approval

The company plans to expand its portfolio in regulated markets aggressively


IPM growth led by Covid  driven products to taper off in Q2FY22: Nirmal Bang
News | October 06, 2021

IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang

In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report


Lupin receives tentative approval for Brexpiprazole tablets
Drug Approval | October 06, 2021

Lupin receives tentative approval for Brexpiprazole tablets

This product will be manufactured at Lupin’s Pithampur facility In India


Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Public Health | October 06, 2021

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

A total of 8308 stores are open across India and medicines are priced at affordable rates


Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Biocon launches Everolimus tablets in the US
Drug Approval | October 04, 2021

Biocon launches Everolimus tablets in the US

According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation
Digitisation | September 30, 2021

TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation

TCS to help Apoteket drive its digital transformation across sales channels and internal processes